Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis

Figure 2

Forest plot of the odds of VTE in ovarian cancer patients that have cancer of stages III and IV at diagnosis (versus stages I and II). This figure shows the pooled odd of stage III/IV cancer (versus stage I/II). The total pooled odds are 2.73 (1.84-4.06).